SCHEMBL15434658

SCHEMBL15434658

COC(=O)Cc1ccncc1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNC P24863 1/20 0.42
CDK8 P49336 1/20 0.42
ALDH1A1 P00352 6/20 0.42
POLB P06746 1/20 0.42
MAPT P10636 1/20 0.42
KDM4E B2RXH2 4/20 0.40
GLA P06280 2/20 0.40
GAA P10253 1/20 0.40
SIRT3 Q9NTG7 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
NOD2 Q9HC29 1/20 0.39
CYP4F2 P78329 1/20 0.39
CYP4A11 Q02928 1/20 0.39
PDGFRB P09619 1/20 0.38
FGFR1 P11362 1/20 0.38
PDGFRA P16234 1/20 0.38
FLT1 P17948 1/20 0.38
FGFR3 P22607 1/20 0.38
KDR P35968 1/20 0.38
NPC1 O15118 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24767640 0.85 ALDH1A1 (0.37) CCNCCDK8ALDH1A1POLBMAPT
SCHEMBL8580162 0.85 PKM (0.43) SIRT3TDP1KMT2A
SCHEMBL18481211 0.83 CCNC (0.42) CCNCCDK8ALDH1A1KDM4EGLA
SCHEMBL18808055 0.81 ALDH1A1 (0.54) CCNCCDK8ALDH1A1MAPTKDM4E
SCHEMBL20517285 0.81 CCNC (0.41) CCNCCDK8ALDH1A1MAPTKDM4E
SCHEMBL8746918 0.80 NAPRT (0.47) CCNCCDK8MAPTKDM4ESIRT3
SCHEMBL18808054 0.79 CCNC (0.40) CCNCCDK8ALDH1A1KDM4EGLA
SCHEMBL26337351 0.79 SIRT3 (0.50) CCNCCDK8ALDH1A1POLBMAPT
SCHEMBL31232942 0.78 NOD2 (0.44) CCNCCDK8ALDH1A1POLBMAPT
SCHEMBL26123956 0.78 NOD2 (0.44) CCNCCDK8ALDH1A1POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017192664-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF WAVE LIFE SCIENCES LTD. (SG) 2017-11-09 WO disclosed
US-20170275621-A1 CHIRAL CONTROL WAVE LIFE SCIENCES USA, INC. 2017-09-28 US disclosed
US-20150211006-A1 CHIRAL CONTROL WAVE LIFE SCIENCES USA, INC. 2015-07-30 US disclosed
WO-2014012081-A2 CHIRAL CONTROL ONTORII, INC. (US) 2014-01-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170275621-A1 CHIRAL CONTROL RNGTT, POLI, NSUN3 CCNC 1048/4885CDK8 2400/4885ALDH1A1 2867/4885
US-20150211006-A1 CHIRAL CONTROL RNGTT, POLI, NSUN3 CCNC 1048/4885CDK8 2400/4885ALDH1A1 2867/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.